MNKD - NASDAQ

MannKind Corporation

MNKD·NASDAQ

$3.49

+1.7%

HealthcareBiotechnology

MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocrinologists, and other healthcare providers for the treatment of hypothyroidism. The company has a license and collaboration agreement with United Therapeutics Corporation. It also has an agreement with NRx Pharmaceuticals to develop a dry powder formulation of ZYESAMI (aviptadil), a synthetic form of human vasoactive intestinal peptide to help protect cells against inflammatory conditions. MannKind Corporation was incorporated in 1991 and is headquartered in Westlake Village, California.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$1.08B

EPS0.0200

P/E Ratio174.50

Earnings Date08/05/2026

mnkd

Accumulated Other Comprehensive Income (Loss)

Last Annual Value

115.00K

3-Year CAGR

5-Year CAGR

10-Year CAGR

23%

Adjust for Inflation

MannKind Corporation Competitors Analysis of Accumulated Other Comprehensive Income (Loss)

MNKD · NASDAQ

Company	Accumulated Other Comprehensive Income (Loss)	CAGR 3Y	CAGR 5Y	CAGR 10Y
MannKind Corporation NASDAQ:MNKD	115.00K	N/A	N/A	N/A
Janux Therapeutics, Inc. NASDAQ:JANX	4.32M	86.5%	N/A	N/A
Biohaven Ltd. NYSE:BHVN	8.35M	N/A	N/A	N/A
Celldex Therapeutics, Inc. NASDAQ:CLDX	3.63M	3.1%	13.9%	3.6%
Harmony Biosciences Holdings, Inc. NASDAQ:HRMY	346.00K	457.2%	N/A	N/A
Sionna Therapeutics, Inc. NASDAQ:SION	540.00K	N/A	N/A	N/A
Vera Therapeutics, Inc. NASDAQ:VERA	786.00K	46.3%	N/A	N/A
Nuvation Bio Inc. NYSE:NUVB	-187.00K	N/A	N/A	N/A

MannKind Corporation Fair Value Envelope

MNKD · NASDAQ

Our analysis suggests that MNKD has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $3.49, this represents a potential HIDDEN relative to our calculated worth for MannKind Corporation.

HIDDEN

Intrinsic Value

Current Price: $3.49

Related Guides

Blog Categories

Continue your MNKD research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.